drugset / Trial / NCT00209729
Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.
Phase 1/2
Suspended
50 enrolled
Hokkaido Gastrointestinal Cancer Study Group
Hokkaido University Hospital · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To assess the usefulness of Docetaxel plus S-1 combination chemotherapy based on the antitumor effect and survival period by performing a phase I/II study of this combination in Elderly patients with inoperable or with postoperative gastric cancer.
Timeline
- Start
- 2005-04
- Primary completion
- 2009-12
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | Intravenous |
| Subject | S-1 | Small molecule | — | Oral |